Page 2 - Deepak Thomas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lupin, Phil Inc partner to deliver solutions for patients on Solosec® Lupin, Phil Inc partner to deliver solutions for patients on Solosec® 02 February 2021 | News Solosec® is the only single 2g oral dose therapy for the most common vaginal infection in the US among adult women Source credit: Lupin Lupin Pharmaceuticals, Inc, a global pharmaceutical company, has announced a partnership with Phil, Inc, which helps deliver cost-effective next-generation access solutions for patients who are prescribed Solosec® (secnidazole) 2g oral granules for the treatment of bacterial vagi...

Share this article Share this article MUMBAI, India and BALTIMORE, Feb. 1, 2021 /PRNewswire/ -- Lupin Pharmaceuticals Inc. (Lupin), global pharmaceutical company, announced today a partnership with Phil, Inc., which helps deliver cost-effective next-generation access solutions for patients who are prescribed Solosec® (secnidazole) 2g oral granules for the treatment of bacterial vaginosis (BV) in adult women. Solosec® is the only single 2g oral dose therapy for the most common vaginal infection in the U.S. among adult women. This treatment is designed to deliver a full course of therapy in...